Anlotinib in combination with pembrolizumab for low-grade myofibroblastic sarcoma of the pancreas: A case report
Rong-Ting Wu, Ji-Cheng Zhang, Cheng-Nan Fang, Xiao-Yu Qi, Jin-Fei Qiao, Ping Li, Li Su · 2023
Read Anlotinib in combination with pembrolizumab for low-grade myofibroblastic sarcoma of the pancreas: A case report by Rong-Ting Wu, Ji-Cheng Zhang, Cheng-Nan Fang, Xiao-Yu Qi, Jin-Fei Qiao, Ping Li, Li Su (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10731194.txt.
Description
Rong-Ting Wu and co-authors report a case of a rare, low-grade sarcoma in the pancreas that returned after surgery and spread. Very few cases of this tumor type in the pancreas exist in print. The mass was found on a routine check, and scans plus tissue tests confirmed the diagnosis, as the 2023 report tells.
Standard treatment failed against the returned, spread disease. With family consent, the team tried a pair of drugs: one that starves tumor blood supply, and one immune drug. Scans and symptoms later showed a fairly good response to the pair. The authors also review past cases to sharpen how this rare tumor is spotted, and offer the drug pair as a strategy worth testing further.
Catalog record
| CREATOR | Rong-Ting Wu, Ji-Cheng Zhang, Cheng-Nan Fang, Xiao-Yu Qi, Jin-Fei Qiao, Ping Li, Li Su |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |